Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.636,79
1,19%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE KV Pharmaceutical Co. CL A (KV.A) KV Pharmaceutical Co. CL A (KV.A) Notizie

KV.A

K V Pharma (KV.A)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:KV.A
DataOraFonteTitoloSimboloCompagnia
16/09/201316:26PR Newswire (US)KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million RecapitalizationNYSE:KV.AKV Pharmaceutical Co. CL A
24/01/201314:00PR Newswire (US)Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%...NYSE:KV.AKV Pharmaceutical Co. CL A
28/12/201218:43PR Newswire (US)K-V Pharmaceutical Receives Court Approval of Hologic SettlementNYSE:KV.AKV Pharmaceutical Co. CL A
13/12/201200:39PR Newswire (US)K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of P...NYSE:KV.AKV Pharmaceutical Co. CL A
10/08/201214:00PR Newswire (US)K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy CourtNYSE:KV.AKV Pharmaceutical Co. CL A
08/08/201217:09PR Newswire (US)K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy CourtNYSE:KV.AKV Pharmaceutical Co. CL A
07/08/201218:16PR Newswire (US)K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC MarketsNYSE:KV.AKV Pharmaceutical Co. CL A
06/08/201213:57PR Newswire (US)K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC MarketsNYSE:KV.AKV Pharmaceutical Co. CL A
04/08/201206:56PR Newswire (US)K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial ObligationsNYSE:KV.AKV Pharmaceutical Co. CL A
03/08/201217:27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NYSE:KV.AKV Pharmaceutical Co. CL A
31/07/201223:09Edgar (US Regulatory)Securities Registration Statement (S-1)NYSE:KV.AKV Pharmaceutical Co. CL A
26/07/201222:27Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NYSE:KV.AKV Pharmaceutical Co. CL A
20/07/201222:05PR Newswire (US)K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing CriteriaNYSE:KV.AKV Pharmaceutical Co. CL A
13/07/201222:43Edgar (US Regulatory)Amended Current report filing (8-K/A)NYSE:KV.AKV Pharmaceutical Co. CL A
06/07/201222:21Edgar (US Regulatory)Current report filing (8-K)NYSE:KV.AKV Pharmaceutical Co. CL A
02/07/201215:15PR Newswire (US)FDA Issues Further Guidance About Makena®NYSE:KV.AKV Pharmaceutical Co. CL A
30/06/201200:51PR Newswire (US)K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing CriteriaNYSE:KV.AKV Pharmaceutical Co. CL A
18/06/201222:36Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NYSE:KV.AKV Pharmaceutical Co. CL A
18/06/201215:14PR Newswire (US)FDA and CMS Issue Important Updates on Makena®NYSE:KV.AKV Pharmaceutical Co. CL A
25/05/201222:15PR Newswire (US)K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market ActivityNYSE:KV.AKV Pharmaceutical Co. CL A
16/05/201223:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
12/04/201222:18PR Newswire (US)K-V Pharmaceutical Company to Present at Imperial Capital 2012 Healthcare Investor ForumNYSE:KV.AKV Pharmaceutical Co. CL A
02/04/201215:01PR Newswire (US)K-V Pharmaceutical Company to Present at Needham & Company 11th Annual Healthcare ConferenceNYSE:KV.AKV Pharmaceutical Co. CL A
14/02/201219:05Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NYSE:KV.AKV Pharmaceutical Co. CL A
10/02/201223:01Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NYSE:KV.AKV Pharmaceutical Co. CL A
09/02/201222:18Edgar (US Regulatory)Quarterly Report (10-Q)NYSE:KV.AKV Pharmaceutical Co. CL A
09/02/201213:30PR Newswire (US)K-V Pharmaceutical Announces Updated Makena® Performance Metrics and Investor Conference CallNYSE:KV.AKV Pharmaceutical Co. CL A
26/01/201221:30Edgar (US Regulatory)Statement of Ownership (SC 13G)NYSE:KV.AKV Pharmaceutical Co. CL A
19/12/201123:12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NYSE:KV.AKV Pharmaceutical Co. CL A
19/12/201122:09Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NYSE:KV.AKV Pharmaceutical Co. CL A
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:KV.A

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network